Mackenzie McQueeney
Surgical · New Hartford, NYNPI 1265020242
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,201 of the $1,612 with a category attached, or 74.5%. 18 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 41.5% of the total. Reporting peaked in 2022 at $855 and has fallen 79.0% since, to $180 in 2025.
Across 53 payments — averaging $30.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$670
- Johnson & Johnson$183
- Sanofi-aventis U.S. LLC$170
- Amgen$100
- Fidia Pharma USA Inc.$60
- Stryker$52
- plus $378 from 12 others
What the payments were for
- Travel & lodging$41126%
- Food & beverage$1,20174%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 8 | $670 |
| Johnson & Johnson | 6 | $183 |
| Sanofi-aventis U.S. LLC | 10 | $170 |
| Amgen | 5 | $100 |
| Fidia Pharma USA Inc. | 4 | $60 |
| Stryker | 2 | $52 |
| Smith+Nephew | 2 | $49 |
| Vertex | 2 | $46 |
| Medacta USA, Inc. | 1 | $44 |
| Bioventus LLC | 2 | $39 |
| Si-bone, Inc. | 2 | $38 |
| Pacira Therapeutics, Inc. | 2 | $38 |
| IBSA Pharma Inc. | 2 | $36 |
| Boston Scientific | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $17 |
| Medtronic | 1 | $16 |
| Heraeus Medical, LLC. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,612 in reported general payments places this provider in the 80th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 62 | $2,281 |
| Celecoxib | 56 | $1,862 |
| Meloxicam | 117 | $304 |
| Naproxen | 24 | $111 |
| Cyclobenzaprine Hcl | 24 | $99 |
| Ibuprofen | 12 | $87 |
| Methylprednisolone | 12 | $56 |
| Oxycodone Hcl | 14 | $47 |
| Amoxicillin | 13 | $8 |
Paid to pharmacies, not to this prescriber.
Other surgical in New Hartford
- Anne ThomsonNew Hartford$7K
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Sarah MartineckWilliamsville$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.